We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Daiichi Sankyo Company Ltd (PK) | USOTC:DSNKY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.735 | 2.18% | 34.395 | 34.30 | 34.48 |
| High Price | Low Price | Open Price | Traded | Last Trade |
|---|---|---|---|---|
| 34.48 | 34.301 | 34.40 | 235,826 | 18:00:45 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 23/10/2023 | 07:49 | DJN | AstraZeneca, Daiichi Sankyo's Enhertu Gets Approval in EU For Lung Cancer.. |
| 20/10/2023 | 01:30 | DJN | Merck, Daiichi Sankyo Ink Commercialization Deal for Up to $22 Billion |
| 22/9/2023 | 07:53 | DJN | AstraZeneca Says Trial Results For Breast Cancer Drug Were Highly Positive |
| 15/9/2023 | 15:51 | DJN | AstraZeneca's Lung-Cancer Treatment Gets Recommended for Approval in the EU |
| 11/9/2023 | 07:55 | DJN | AstraZeneca Says Datopotamab Deruxtecan Combined With Imfinzi Shows High.. |
| 03/7/2023 | 07:50 | DJN | AstraZeneca Says Datopotamab Deruxtecan Phase 3 Trial Shows Positive.. |
1 Year Daiichi Sankyo (PK) Chart |
Intraday Daiichi Sankyo (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
